Severe Hypoglycemia in Diabetes Drug Approved in Europe

A marketing authorization for Zegalogue (dasiglucagon, Zealand Pharma) for the treatment of severe hypoglycemia in patients aged 6 years and older with diabetes has been recommended by the European Medicines Agency (EMA). Severe hypoglycemia is defined as having low blood glucose levels that requires assistance from another person to treat…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button